Biotechnology Company Announces Exclusive Licensing Agreement For Mental Disorder Treatment
The Dawn of a New Era in Mental Health Treatment: Clearmind Medicine's Revolutionary Psychedelic Compounds.
Clearmind Medicine Inc., has recently announced an exclusive licensing agreement that could fundamentally transform the landscape of mental health therapy. This partnership with Yissum Research Development Company of the Hebrew University of Jerusalem heralds the arrival of generation 3.0 psychedelic compounds, poised to revolutionize the treatment of addiction and mental disorders. $Clearmind Medicine(CMND.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
